EventsCliniciansResearchersATMPsRegulationResearchRodrigo Ortiz 15 April 2025 ADVANCE 5-day Summer School on Cell and Gene Therapies The next ADVANCE school on ATMP from Faculty of Pharmacy will happen here in Ljubljana. We think is a great FREE opportunity to learn more about ATMPs. Learn more in the official page of ... More
EventsPacientsBusiness ModelInvestmentCTGCTNICRodrigo Ortiz 13 March 2025 Event Date: 12 March 2025 do: 12 March 2025 • Prime Minister of Slovenia Dr. Robert Golob visits the Kemijski Inštitut to discuss the CTGCT plans Yesterday, Dr. Robert Golob, Prime Minister of the Slovenian Government, visited the Kemijski inštitut - National Institute of Chemistry. More
EventsCliniciansResearchersGen TherapyResearchCTGCTRodrigo Ortiz 12 March 2025 Event Date: 17 March 2025 • 14:00 do: 17 March 2025 • 15:00 Gene Therapy: Triumphs, Challenges, and Future Directions Lecture by Luis Pereira de Almeida on the 17th of March at the Kemijski Inštitut More
ArticlesCliniciansResearchersATMPsCell therapyGen TherapyManufacturing ProcessRegulationCTGCTUMCUtrechtRodrigo Ortiz 5 March 2025 Navigating Viral Vector Production for Gene Therapy This week we had the opportunity to listen to Ganesh Ramesh, a PhD candidate at the Viral Vector Production Center for Translation Immunology of UMC Utrecht, under the supervision of Dr. Zsolt Sebestyen. Here ... More
ArticlesPacientsATMPsCell therapyGen TherapyBusiness ModelEconomicsPre ClinicalResearchCTGCTNICRodrigo Ortiz 28 February 2025 How Patient Advocacy is Driving Breakthroughs to Treat CTNNB1 Syndrome Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ... More
ArticlesCliniciansPacientsResearchersATMPsCell therapyResearchCTGCTNICRodrigo Ortiz 25 February 2025 Controlling Cells With Chemically Switchable Antibodies: A New Opportunity For Precision Therapy Imagine being able to turn a cell’s behavior ON or OFF, just like flipping a light switch. That’s exactly what scientists have achieved with the innovative technology presented in this paper published in the ... More
ArticlesPacientsResearchersGen TherapyLaboratoryPre ClinicalResearchCTGCTNICRodrigo Ortiz 28 January 2025 The research on combining cytokines with pyroptosis is gaining widespread media coverage Research on combining cytokines and pyroptosis for cancer therapy by Slovenian scientists has gained significant media recognition, including TV features, articles, and the honor of being named "Names of the Week". More
Media ReleasesPacientsResearchCTGCTNICRodrigo Ortiz 10 January 2025 Head of CTGCT research selected as breakthrough discovery by the national TV in Slovenia Check this video were he Head of the #CTGCT prof. dr. Mojca Benčina appeared in the news of the Slovenian national TV since her researched was selected as one of the breakthrough discoveries by ... More
ArticlesCliniciansPacientsCell therapyGen TherapyLaboratoryPre ClinicalResearchCTGCTNICRodrigo Ortiz 7 January 2025 Combining cytokines and pyroptosis, a promising weapon against cancer A recent study published in Nature Communications has unveiled a groundbreaking approach that combines the power of cytokines with a type of cell death called pyroptosis to boost the immune system's ability to fight ... More
LatestMedia ReleasesCliniciansPacientsResearchersResearchCTGCTRodrigo OrtizRodrigo Ortiz 11 December 2024 CTGCT Newsletter, 1st year in review Welcome to the first CTGCT Newsletter featuring a selection of the articles we're most proud of in the last year. More
ArticlesMedia ReleasesResearchersATMPsCell therapyGen TherapyResearchCharite BerlinCTGCTNICTUDUCLUMCUtrechtRodrigo Ortiz 6 December 2024 CTGCT’s Innovation Report on Gene and Cell Therapy We are pleased to share that our latest paper has been accepted for publication in the Computational and Structural Biotechnology Journal (CSBJ) More
ArticlesPacientsGen TherapyDrug DiscoveryLaboratoryResearchCTGCTNICRodrigo Ortiz 22 November 2024 MyD88 balances cell homeostasis by regulating immune response, mitochondrial function and cell death A recent study by researchers in the CTGCT investigates the role of the MyD88 protein, a key player in innate immune signaling pathways. More